Increasing SARS-CoV-2 seroprevalence among UK pediatric patients on dialysis and kidney transplantation between January 2020 and August 2021
ConclusionsAnti-SARS-CoV-2 seroprevalence was low in 2020 and increased in early 2021. Serological surveillance complements nucleic acid detection and antigen testing to build a greater picture of the epidemiology of COVID-19 and is therefore important to guide public health responses.Graphical abstractA higher resolution version of the Graphical abstract is available asSupplementary information
Source: Pediatric Nephrology - Category: Urology & Nephrology Source Type: research
More News: Coronavirus | Covid Vaccine | COVID-19 | Dialysis | Epidemiology | Hemodialysis | International Medicine & Public Health | Kidney Transplant | Kidney Transplantation | Laboratory Medicine | Pandemics | Pediatrics | Peritoneal Dialysis | Respiratory Medicine | SARS | Transplants | Urology & Nephrology | Vaccines | WHO